Algernon Pharmaceuticals Statistics

Total Valuation

CSE:AGN has a market cap or net worth of CAD 2.39 million. The enterprise value is 2.30 million.

Market Cap	2.39M
Enterprise Value	2.30M

Important Dates

The next estimated earnings date is Friday, July 25, 2025.

Earnings Date	Jul 25, 2025
Ex-Dividend Date	n/a

Share Statistics

CSE:AGN has 34.21 million shares outstanding. The number of shares has increased by 30.54% in one year.

Current Share Class	34.21M
Shares Outstanding	34.21M
Shares Change (YoY)	+30.54%
Shares Change (QoQ)	+0.00%
Owned by Insiders (%)	11.85%
Owned by Institutions (%)	13.30%
Float	30.15M

Valuation Ratios

The trailing PE ratio is 6.49.

PE Ratio	6.49
Forward PE	n/a
PS Ratio	n/a
PB Ratio	1.69
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	8.55
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.08

Current Ratio	0.08
Quick Ratio	0.06
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 29.05% and return on invested capital (ROIC) is -102.44%.

Return on Equity (ROE)	29.05%
Return on Assets (ROA)	-25.89%
Return on Invested Capital (ROIC)	-102.44%
Return on Capital Employed (ROCE)	-107.26%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -43.48% in the last 52 weeks. The beta is 1.90, so CSE:AGN's price volatility has been higher than the market average.

Beta (5Y)	1.90
52-Week Price Change	-43.48%
50-Day Moving Average	0.08
200-Day Moving Average	0.08
Relative Strength Index (RSI)	33.73
Average Volume (20 Days)	184,980

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-1.52M
Pretax Income	269,144
Net Income	269,144
EBITDA	-1.50M
EBIT	-1.52M
Earnings Per Share (EPS)	0.01

Full Income Statement

Balance Sheet

The company has 92,181 in cash and n/a in debt, giving a net cash position of 92,181 or 0.00 per share.

Cash & Cash Equivalents	92,181
Total Debt	n/a
Net Cash	92,181
Net Cash Per Share	0.00
Equity (Book Value)	1.42M
Book Value Per Share	0.05
Working Capital	-1.81M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-2.88M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CSE:AGN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-30.54%
Shareholder Yield	n/a
Earnings Yield	11.24%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

The last stock split was on March 3, 2023. It was a forward split with a ratio of 4.

Last Split Date	Mar 3, 2023
Split Type	Forward
Split Ratio	4

Scores

Altman Z-Score	n/a
Piotroski F-Score	2